gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation

Advances in Experimental Medicine and Biology

Volumn 586, Issue , 2006, Pages 95-105

  Ghebrehiwet, Berhane ^a   Cebadamora, Claudia ^a   Tantral, Lee ^a   Jesty, Jolyon ^a   Peerschke, Ellinor I B ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934435093     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-34134-X_7     Document Type: Conference Paper

References (30)

1. B. Ghebrehiwet, B. L. Lim, E. I. B. Peerschke, A. C. Willis, and K.B.M. Reid, Isolation cDNA cloning, and overexpression of a 33-kDa cell surface glycoprotein that binds to the globular "heads" of C1q, J Exp Med 179,1809-1821 (1994).
2. B. Ghebrehiwet, B.-L. Lim, R. Kumar, X. Feng, and E.I.B. Peerschke, gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection, Immunol Rev 180, 65-77 (2001).
3. G. Marques, L.C. Anton, E. Barrio, A. Sanchez, S. Ruiz, F. Gavilanes, and F. Vivanco, Arginine residues of the globular regions of human C1q involved in the interaction with immunoglobulin G. J Biol Chem 268,10393-10402 (1993).
4. B. Ghebrehiwet, P.D. Lu, W. Zhang, B.-L. Lim, P. Eggleton, L.E.A. Leigh, K.B.M. Reid, and E.I.B. Peerschke, Identification of functional domains on gC1q-R, a cell surface protein which binds to the globular heads ofC1q,using monoclonal antibodies and synthetic peptide. Hybridoma 15, 333-343 (1996.).
5. J.Y. Jianzhong, Zhang, A. Krainer, and R-M. Xu, Crystal structure of p32, a doughnut-shaped acidic mitochondrial matrix protein. Proc Natl Acad Sci USA 96, 3572-3577 (1999).
6. B. Ghebrehiwet, J. Jesty, and E.I.B. Peerschke, gC1q-R/p33: structure-function predictions from the crystal structure. Immunobiology 205, 421-432 (2002).
7. G.J. Arlaud, C. Gaboriaud, N.M. Thielens, V. Rossi, B. Bersch, J-F. Hernandez, and J.C. Fontecilla-Camps, Structural biology of C1: dissection of a complex molecular machinery. Immunol Rev 180,136-145 (2001).
8. K.B.M Reid, Preparation of human C1q, a subcomponent of the first component of the classical pathway of complement. Methods Enzymol 80,16-25 (1981).
9. W.P. Kolb, L.M. Kolb, and E.R. Podack, C1q: isolation from human serum inhigh yield by affinity chromatography and development of a highly sensitive hemolyticassay. J Immunol 122, 2103-2111 (1979).
10. S.R. Cole, L.K. Ashmand,, and P.L.Ey, Biotinylation: an alternative to radioiodination for the identification of cell surface antigens in immunoprecipitates. Mol Immunol 24, 699-705 (1987).
11. B-L. Lim, K. Preissner, B. Ghebrehiwet, L.E.A. Leigh, and K.B.M. Reid, The binding protein for globular "heads" of complement C1q, gC1q-R: Functional expression and characterization as a novel vitronectin binding factor. J Biol Chem 271, 26739-26744 (1996).
12. K. Peterson, W. Zhang, P.D. Lu, S.A. Keilbaugh, E.I.P. Peerschke and B. Ghebrehiwet, The C1q binding membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular localization and immunochemical characterization. Clin Immunol Immunopathol 84, 17-26 (1997).
13. M.A. Blajchman and A.H. Ozge-Anwar, The role of the complement system in hemostasis. Prog Hematol 14,149-159 (1986).
14. B. Ghebrehiwet, M. Silverberg, and A.P. Kaplan, Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med 152, 665-676 (1981).
15. K. Yasojima, C. Schwab, E.G. McGeer, and P.L. McGeer, Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21,1214-1219 (2001).
16. E.I.B. Peerschke, J.O. Minta, S.Z. Zhou, A. Bini, A. Gotlieb, R.W. Colman and B. Ghebrehiwet, gC1q-R/p33 expression on human coronary artery atherosclerotic lesions. Mol Immunol 41,759-766 (2004).
17. M. Kaul, and M. Loos, The Fc-recognizing collagen-like C1q molecule is a putative type II membrane protein of macrophages. Behring Mitt 93, 171-179 (1993).
18. Z. Vegh-Goyarts, E. Goyarts, K. Rozengarten, A. Mazumder and B. Ghebrehiwet, Maturation-dpendent expression of cC1q-R and gC1q-R on human monocyte derived dendritic cells. Int Immunopharmacol 3, 345-357 (2003).
19. G. Castellano, A.M. Woltman, A.J. Nauta, A. Ross, L.A. Trouw, M.A. Seelen, F.P. Schena, M. Daha, and C. van Kooten. 2004. Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood 103, 3813-3820.
20. L.E.A. Leigh, B. Ghebrehiwet, T.P.S. Perera, I.N. Bird, P. Strong, U. Kishore, K.B.M. Reid and P.Eggleton, C1q-mediated chemotaxis by human neutrophils: involvement of gC1q-R and G-protein signaling mechanisms. Biochem J 330, 247-254(1998).
21. C. Lozada, R. I. Levin, M. Huie, R. Hirschhorn, D. Naime, M. Whittlow, P. A. Recht, B. Golden, and B. Cronstein, Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intracellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci USA 92, 8378-8382(1995).
22. R.H. van den Berg, M.C. Faber-Krol, R.B. Sim, and M.R. Daha The first subcomponent of complement C1q triggers the production of IL-6,Il-8 and chemoattractant peptide 1 by human umbilical vein endothelial cells. J Immunol 161, 6924-6934 (1998).
23. A.P. Kaplan, K. Joseph, Y. Shibayama, S. Reddigari, B. Ghebrehiwet and M. Silverberg, The intrinsic coagulation-kinin forming cascade: assembly in plasma and cell surface in inflammation. Adv Immunol 66, 225-272 (1997).
24. K. Joseph, B. Ghebrehiwet, and A.P. Kaplan, Activation of the kinin-forming cascade on the surface of endothelial cells. Biochem J 382, 71-75 (2001).
25. D. Regoli and J. Barabe, Pharmacology of bradykinin and related kinins, Pharmacol Rev 32, 1-46 (1980).
26. M. Cugno, J. Nussberger, M. Cicardi, and A. Agostoni, Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 3, 311-317 (2003).
27. T.R. Fields, A.P. Kaplan, and B. Ghebrehiwet, Kinin formation in hereditary angioedema plasma: Evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol 72, 54-60 (1983).
28. J. Wu, T. Akaike, T. Havashida, T. Okamoto, A. Okuvama, and H. Maeda, Enhanced vascular permeability in solid tumor involving peroxinitrite and matrix metalloproteinases. Jpn J Cancer Res 92, 439-451 (2001).
29. K. Ishihara, M. Kamata, I. Hayashi, S. Yamashina, M. Majima, Role of bradykinin in vascular permeability and angiogenesis in solid tumor. Int Immunopharmacol 2, 499-509 (2002).
30. B. Ghebrehiwet, M. Silverberg, and A.P. Kaplan, Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med 153, 665-676 (1981).